ABIONYX Pharma S.A.

ABNX.PA · PAR
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents€3,235€4,104€4,046€7,935
Short-Term Investments€0€0€0€0
Receivables€2,295€2,495€1,297€1,569
Inventory€211€221€147€177
Other Curr. Assets€118€66€2,082€3,330
Total Curr. Assets€5,859€6,886€7,572€13,011
Property Plant & Equip (Net)€1,984€2,215€2,559€3,066
Goodwill€5,377€5,377€5,377€5,377
Intangibles€77€80€75€78
Long-Term Investments€133€83€124€114
Tax Assets€0€0-€124-€114
Other NC Assets€20€193€240€300
Total NC Assets€7,591€7,948€8,251€8,821
Other Assets€0€0€0€0
Total Assets€13,450€14,834€15,823€21,832
Liabilities
Payables€1,629€1,439€1,853€2,705
Short-Term Debt€1,184€815€870€1,054
Tax Payable€0€225€171€401
Deferred Revenue€300€0€0€1,774
Other Curr. Liab.€592€1,446€2,200€813
Total Curr. Liab.€3,705€3,925€5,094€6,747
LT Debt€1,914€2,575€3,143€3,904
Deferred Rev, NC€0€0€0€0
Deferred Tax Liab, NC€0€0€0€0
Other NC Liab.€407€412€417€504
Total NC Liab.€2,321€2,987€3,560€4,408
Other Liabilities€0€0€0€0
Cap. Leases€1,644€1,783€2,107€2,652
Total Liabilities€6,026€6,912€8,654€11,155
Equity
Pref Stock€0€1,895€2,619€169,732
Common Stock€1,747€1,623€1,418€1,396
Retained Earnings€1-€3,518-€4,206-€5,822
AOCI-€2,587-€2,562-€2,619-€169,732
Other Equity€8,263€9,817€9,957€15,103
Total Equity€7,424€7,922€7,169€10,677
Supplemental Information
Minority Interest€0€0€0€0
Total Liab. & Tot. Equity€13,450€14,834€15,823€21,832
Net Debt-€137-€714-€33-€2,977
ABIONYX Pharma S.A. (ABNX.PA) Financial Statements & Key Stats | AlphaPilot